Sharda Cropchem has announced strong financial results for the fiscal year ended March 31, 2026. The company reported a significant increase in annual revenue to ₹526,758 lakhs, with a consolidated net profit of ₹68,099 lakhs. Demonstrating commitment to shareholder returns, the Board of Directors has recommended a final dividend of ₹9.00 per equity share for the financial year 2025-26, pending shareholder approval at the upcoming Annual General Meeting.
Annual Financial Performance
For the financial year ended March 31, 2026, Sharda Cropchem delivered robust growth. The company achieved a consolidated annual revenue from operations of ₹526,758 lakhs, compared to ₹431,985 lakhs in the previous year. Consolidated net profit for the year surged to ₹68,099 lakhs, marking a substantial improvement from ₹30,441 lakhs reported in the prior fiscal period.
Segment Analysis
The company operates across two primary segments: Agrochemicals and Non-agrochemicals. The Agrochemicals business remained the primary growth driver, contributing ₹471,685 lakhs in revenue for the year. The segment results for Agrochemicals stood at ₹68,487 lakhs, reflecting the company’s strong global market presence and operational efficiency. The Non-agrochemicals segment, covering belts, dyes, and general chemicals, contributed ₹55,072 lakhs in revenue.
Dividend Recommendation
Reflecting the company’s solid financial health and commitment to delivering value to its investors, the Board of Directors has recommended a final dividend of ₹9.00 per equity share (face value of ₹10.00) for the financial year 2025-26. This dividend is subject to approval by shareholders at the forthcoming Annual General Meeting.
Operational Highlights
Sharda Cropchem continues to scale its global footprint, managing a network of 28 subsidiaries, including various step-down subsidiaries across multiple international jurisdictions. The company’s focus remains on maintaining its asset-light model while navigating the seasonal complexities of the global agrochemical market.
Source: BSE
